Buch, Englisch, 296 Seiten, Previously published in hardcover, Format (B × H): 155 mm x 235 mm, Gewicht: 470 g
Opportunities and Threats for Foreign Companies
Buch, Englisch, 296 Seiten, Previously published in hardcover, Format (B × H): 155 mm x 235 mm, Gewicht: 470 g
ISBN: 978-3-642-06140-0
Verlag: Springer
At detailed look at China’s increasingly important chemical and pharmaceutical industry. One central aspect is the political and economic situation in China with its strategic and operational implications for Western chemical and pharma companies. Numerous case examples describe how Western companies, such as BASF, Bayer, Bicoll, Ciba, Degussa, DSM and Novartis are managing their market entry in China. The book also analyzes the threat of Western companies in their home markets by Chinese competitors.
Zielgruppe
Professional/practitioner
Autoren/Hrsg.
Fachgebiete
- Wirtschaftswissenschaften Betriebswirtschaft Bereichsspezifisches Management Außenhandel
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pharmazie
- Wirtschaftswissenschaften Wirtschaftssektoren & Branchen Fertigungsindustrie Pharmaindustrie
- Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Kosmetische Technologie
- Wirtschaftswissenschaften Wirtschaftssektoren & Branchen Fertigungsindustrie Chemische Industrie
- Wirtschaftswissenschaften Betriebswirtschaft Management Internationales Management
- Wirtschaftswissenschaften Wirtschaftssektoren & Branchen Fertigungsindustrie Automobilindustrie
Weitere Infos & Material
The Chemical Industry in China.- The Global Chemical Industry.- The Petrochemical Industry in China.- Activities of European Chemical Companies in China.- Research and Development in China.- Chemical Industry Parks in China.- Trends in the Chinese Fine Chemicals Market — Opportunities and Threats for the European Fine Chemicals Industry.- Chemicals for China's Chip Industry.- The Pharmaceutical Industry in China.- China's Pharmaceutical Market: Business Environment and Market Dynamics.- Developing the Pharmaceutical Business in China — The Case of Novartis.- China's Approach to Innovative Pharmaceutical R&D: A Review.- Foreign Direct Investment by Multinational Corporations in China — The Pharmaceutical Sector.- Competing in the Chinese Antibiotics Market — Cephalosporins 1982–2000.- The Experience of Successful European Companies in China.- Swimming Ahead of the Shoal — The History of BASF in Greater China.- Establishing a Competitive Production Network in Asia.- Bayer — A Multinational Committed to China.- Bicoll — The First Sino-German Biotechnology Company.- Ciba Specialty Chemicals in China — Global Direction and Local Expertise.- Degussa: Transforming the China Region.- A Toolbox for China — Lessons from the China Experience of Degussa Construction Chemicals.- DSM in China: In Touch with Evolving Needs in the Specialty Chemicals Market.- Vitamins — Opportunities and Challenges for Both Western and Chinese Producers.
